Protega Pharms patents expiration

1. Roxybond patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7955619 PROTEGA PHARMS Abuse resistant drugs, method of use and method of making
Aug, 2028

(4 years from now)

US10314788 PROTEGA PHARMS Pharmaceutical compositions configured to deter dosage form splitting
Aug, 2028

(4 years from now)

Drugs and Companies using OXYCODONE HYDROCHLORIDE ingredient

Market Authorisation Date: 20 April, 2017

Treatment: NA


More Information on Dosage

ROXYBOND family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic